Literature DB >> 29677262

Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.

Alex Tsodikov1, Roman Gulati2, Ruth Etzioni2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29677262     DOI： 10.7326/L17-0738

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  4 in total

1.  [Reply to: PSA screening : Possible uses and harm by N. Keller, M. Jenny, G. Gigerenzer, R. Ablin].

Authors:  Carsten Stephan; Thorsten Schlomm; Klaus Jung
Journal:  Urologe A       Date:  2018-07       Impact factor: 0.639

Review 2.  Role of Multiparametric Magnetic Resonance Imaging in Predicting Pathologic Outcomes in Prostate Cancer.

Authors:  Niklas Harland; Arnulf Stenzl; Tilman Todenhöfer
Journal:  World J Mens Health       Date:  2020-06-24       Impact factor: 5.400

3.  Prostate-specific antigen testing and opportunistic prostate cancer screening: a cohort study in England, 1998-2017.

Authors:  Ashley Kieran Clift; Carol Ac Coupland; Julia Hippisley-Cox
Journal:  Br J Gen Pract       Date:  2021-01-28       Impact factor: 5.386

4.  Correlation of SUVmax and Apparent Diffusion Coefficient Values Detected by Ga-68 PSMA PET/MRI in Primary Prostate Lesions and Their Significance in Lymph Node Metastasis: Preliminary Results of an On-going Study

Authors:  Lebriz Uslu-Beşli; Barış Bakır; Sertaç Asa; Ekrem Güner; Çetin Demirdağ; Onur Erdem Şahin; Emre Karayel; Muhammet Sait Sağer; Haluk Burçak Sayman; Kerim Sönmezoğlu
Journal:  Mol Imaging Radionucl Ther       Date:  2019-09-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.